Cargando…

Validation of an Antimicrobial Stewardship Driven Verigene® Blood-Culture Gram-Negative Treatment Algorithm to Improve Appropriateness of Antibiotics

BACKGROUND: Gram-negative bacteremia (GNB) is associated with significant morbidity and mortality, emphasizing the need for timely, effective antimicrobial therapy. In comparison to conventional diagnostic methods, Verigene® Blood-Culture Gram-Negative (VBC-GN) is a microarray rapid diagnostic test...

Descripción completa

Detalles Bibliográficos
Autores principales: Schlaffer, Kathryn, Heil, Emily, Leekha, Surbhi, Johnson, J Kristie, Claeys, Kimberly
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631054/
http://dx.doi.org/10.1093/ofid/ofx163.1650
_version_ 1783269357583859712
author Schlaffer, Kathryn
Heil, Emily
Leekha, Surbhi
Johnson, J Kristie
Claeys, Kimberly
author_facet Schlaffer, Kathryn
Heil, Emily
Leekha, Surbhi
Johnson, J Kristie
Claeys, Kimberly
author_sort Schlaffer, Kathryn
collection PubMed
description BACKGROUND: Gram-negative bacteremia (GNB) is associated with significant morbidity and mortality, emphasizing the need for timely, effective antimicrobial therapy. In comparison to conventional diagnostic methods, Verigene® Blood-Culture Gram-Negative (VBC-GN) is a microarray rapid diagnostic test that identifies eight target GN organisms and six genetic resistance determinants. This study examined the potential clinical impact of VBC-GN coupled with a proposed antimicrobial stewardship (AMS)-derived treatment algorithm to guide timely, appropriate antimicrobial therapy in GNB. METHODS: Retrospective, single-center, study of adult patients (≥ 18 years) with GNB at University of Maryland Medical Center (UMMC) from September 2015 – May 2016. Patient clinical characteristics, co-morbidities, and antimicrobials administered were collected. Appropriateness of antimicrobial therapy was by in vitro susceptibility. Appropriateness of actual empiric antimicrobials received as standard care were compared with theoretical antimicrobials as guided by the UMMC AMS treatment algorithm. Two investigators (KCC and ELH) independently evaluated appropriateness of empiric and algorithm antimicrobial recommendations. RESULTS: 188 patients (median age 57.0 (IQR 46.5 – 65.0) years) with GNB were included and 143 (76.1%) were positive for target GN organisms. Eight (4.3%) cases were GN polymicrobial, 8 (4.3%) were CTX-M positive. E. coli was the most common target GN organism (30.3%), and genitourinary was the most common source (29.3%). There was a good level of agreement between reviewers regarding appropriateness of empiric therapy (Kappa = 0.735) and algorithm recommendations (Kappa = 0.855). Overall, the proposed algorithm would have resulted in 88.4% of cases receiving appropriate antimicrobial therapy vs 78.1% actual empiric antimicrobials (P = 0.014). The AMS treatment algorithm would have resulted in 14.4% appropriate de-escalation, 4.8% inappropriate de-escalation, 5.3% appropriate escalation, and 16.0% unnecessary escalation. CONCLUSION: Proposed antibiotics by AMS-derived treatment algorithm applied in conjunction with rapid diagnostic testing would result in a significantly higher proportion of patients receiving appropriate antimicrobial therapy vs. standard care. DISCLOSURES: J. K. Johnson, Nanosphere: Grant Investigator, Grant recipient
format Online
Article
Text
id pubmed-5631054
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-56310542017-11-07 Validation of an Antimicrobial Stewardship Driven Verigene® Blood-Culture Gram-Negative Treatment Algorithm to Improve Appropriateness of Antibiotics Schlaffer, Kathryn Heil, Emily Leekha, Surbhi Johnson, J Kristie Claeys, Kimberly Open Forum Infect Dis Abstracts BACKGROUND: Gram-negative bacteremia (GNB) is associated with significant morbidity and mortality, emphasizing the need for timely, effective antimicrobial therapy. In comparison to conventional diagnostic methods, Verigene® Blood-Culture Gram-Negative (VBC-GN) is a microarray rapid diagnostic test that identifies eight target GN organisms and six genetic resistance determinants. This study examined the potential clinical impact of VBC-GN coupled with a proposed antimicrobial stewardship (AMS)-derived treatment algorithm to guide timely, appropriate antimicrobial therapy in GNB. METHODS: Retrospective, single-center, study of adult patients (≥ 18 years) with GNB at University of Maryland Medical Center (UMMC) from September 2015 – May 2016. Patient clinical characteristics, co-morbidities, and antimicrobials administered were collected. Appropriateness of antimicrobial therapy was by in vitro susceptibility. Appropriateness of actual empiric antimicrobials received as standard care were compared with theoretical antimicrobials as guided by the UMMC AMS treatment algorithm. Two investigators (KCC and ELH) independently evaluated appropriateness of empiric and algorithm antimicrobial recommendations. RESULTS: 188 patients (median age 57.0 (IQR 46.5 – 65.0) years) with GNB were included and 143 (76.1%) were positive for target GN organisms. Eight (4.3%) cases were GN polymicrobial, 8 (4.3%) were CTX-M positive. E. coli was the most common target GN organism (30.3%), and genitourinary was the most common source (29.3%). There was a good level of agreement between reviewers regarding appropriateness of empiric therapy (Kappa = 0.735) and algorithm recommendations (Kappa = 0.855). Overall, the proposed algorithm would have resulted in 88.4% of cases receiving appropriate antimicrobial therapy vs 78.1% actual empiric antimicrobials (P = 0.014). The AMS treatment algorithm would have resulted in 14.4% appropriate de-escalation, 4.8% inappropriate de-escalation, 5.3% appropriate escalation, and 16.0% unnecessary escalation. CONCLUSION: Proposed antibiotics by AMS-derived treatment algorithm applied in conjunction with rapid diagnostic testing would result in a significantly higher proportion of patients receiving appropriate antimicrobial therapy vs. standard care. DISCLOSURES: J. K. Johnson, Nanosphere: Grant Investigator, Grant recipient Oxford University Press 2017-10-04 /pmc/articles/PMC5631054/ http://dx.doi.org/10.1093/ofid/ofx163.1650 Text en © The Author 2017. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Schlaffer, Kathryn
Heil, Emily
Leekha, Surbhi
Johnson, J Kristie
Claeys, Kimberly
Validation of an Antimicrobial Stewardship Driven Verigene® Blood-Culture Gram-Negative Treatment Algorithm to Improve Appropriateness of Antibiotics
title Validation of an Antimicrobial Stewardship Driven Verigene® Blood-Culture Gram-Negative Treatment Algorithm to Improve Appropriateness of Antibiotics
title_full Validation of an Antimicrobial Stewardship Driven Verigene® Blood-Culture Gram-Negative Treatment Algorithm to Improve Appropriateness of Antibiotics
title_fullStr Validation of an Antimicrobial Stewardship Driven Verigene® Blood-Culture Gram-Negative Treatment Algorithm to Improve Appropriateness of Antibiotics
title_full_unstemmed Validation of an Antimicrobial Stewardship Driven Verigene® Blood-Culture Gram-Negative Treatment Algorithm to Improve Appropriateness of Antibiotics
title_short Validation of an Antimicrobial Stewardship Driven Verigene® Blood-Culture Gram-Negative Treatment Algorithm to Improve Appropriateness of Antibiotics
title_sort validation of an antimicrobial stewardship driven verigene® blood-culture gram-negative treatment algorithm to improve appropriateness of antibiotics
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631054/
http://dx.doi.org/10.1093/ofid/ofx163.1650
work_keys_str_mv AT schlafferkathryn validationofanantimicrobialstewardshipdrivenverigenebloodculturegramnegativetreatmentalgorithmtoimproveappropriatenessofantibiotics
AT heilemily validationofanantimicrobialstewardshipdrivenverigenebloodculturegramnegativetreatmentalgorithmtoimproveappropriatenessofantibiotics
AT leekhasurbhi validationofanantimicrobialstewardshipdrivenverigenebloodculturegramnegativetreatmentalgorithmtoimproveappropriatenessofantibiotics
AT johnsonjkristie validationofanantimicrobialstewardshipdrivenverigenebloodculturegramnegativetreatmentalgorithmtoimproveappropriatenessofantibiotics
AT claeyskimberly validationofanantimicrobialstewardshipdrivenverigenebloodculturegramnegativetreatmentalgorithmtoimproveappropriatenessofantibiotics